Nonexudative Macular Neovascularization in Age-Related Macular Degeneration - Takeaways - MDSpire

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

  • By

  • Sridevi Thottarath

  • Sarega Gurudas

  • Syed Kubravi

  • Dimitrios Kazantzis

  • Ayse Merve Keskin

  • Sobha Sivaprasad

  • EYENEON Study Group

  • Benjamin Burton

  • Geeta Menon

  • Manju Chandran

  • Ian Pearce

  • Savita Madhusudhan

  • Anna Grabowska

  • Faruque Ghanchi

  • James Talks

  • Richard Gale

  • Martin McKibbin

  • Ajay Kotagiri

  • Niro Narendran

  • Afsar Jafree

  • Saad Younis

  • Claire Bailey

  • Priya Prakash

  • Christiana Dinah

  • Louise Downey

  • Andrew Lottery

  • Paritosh Shah

  • Romi Chhabra

  • Narendra Dhingra

  • Indra Dias

  • Mary Freeman

  • Daren Hanumunthadu

  • May 1, 2026

  • 0 min

Share

  • 1

    Subclinical nonexudative macular neovascularization (neMNV) is a significant risk factor for exudative age-related macular degeneration (nAMD).

  • 2

    The prevalence of neMNV in fellow eyes of unilateral exudative AMD patients varies widely, ranging from 6.25% to 27.00% based on study timing.

  • 3

    Double-layer sign (DLS) on optical coherence tomography (OCT) is often evaluated as a surrogate for neMNV, but its reliability is uncertain.

  • 4

    The EYENEON study aimed to assess the prevalence of neMNV and DLS in fellow eyes of patients with unilateral new-onset exudative nAMD.

  • 5

    The study included patients aged 50 to 100 years with unilateral treatment-naive exudative nAMD and utilized OCT and OCT-A for imaging.

Original Source(s)

Nonexudative Macular Neovascularization in Age-Related Macular Degeneration

  • by Sridevi Thottarath, Sarega Gurudas, Syed Kubravi, Dimitrios Kazantzis, Ayse Merve Keskin, Sobha Sivaprasad, EYENEON Study Group, Benjamin Burton, Geeta Menon, Manju Chandran, Ian Pearce, Savita Madhusudhan, Anna Grabowska, Faruque Ghanchi, James Talks, Richard Gale, Martin McKibbin, Ajay Kotagiri, Niro Narendran, Afsar Jafree, Saad Younis, Claire Bailey, Priya Prakash, Christiana Dinah, Louise Downey, Andrew Lottery, Paritosh Shah, Romi Chhabra, Narendra Dhingra, Indra Dias, Mary Freeman, Daren Hanumunthadu

  • May 1, 2026

Related Content

Evaluation of Parafoveal Retinal Function in Epiretinal Membrane Foveoschisis: A Pilot Study Comparing ERM Phenotypes via MP-3 Microperimetry

Diagnosing and Managing Polypoidal Choroidal Vasculopathy

Polypoidal choroidal vasculopathy (PCV) is a distinct choroidal vascular disorder often considered a variant of age-related macular degeneration (AMD), although features such as drusen, pigmentary changes, and geographic atrophy are uncommon.

Highlights From Atlantic Coast Retina Club and Macula 2026

Renowned ophthalmologists gathered in Philadelphia to discuss groundbreaking strategies and cases at the Atlantic Coast Retina Club and Macula 2026 conference.